Related Experiment Video

Updated: Oct 1, 2025

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation
09:37

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation

Published on: March 15, 2018

13.3K

Thrap3 promotes osteogenesis by inhibiting the degradation of Runx2

Lei Zhou1,2, Haoran Li1, Shiwei Sun1

  • 1Department of Orthopedics, Shanghai Fifth People's Hospital, Fudan University, Shanghai, China.

FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|March 1, 2022
PubMed

Insights

Thrap3 promotes osteoblast differentiation by stabilizing Runx2, a key protein in bone formation. This occurs via interaction with Sox9, revealing a novel Thrap3-Sox9-Runx2 pathway for osteoporosis treatment.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • Osteoporosis pathogenesis involves impaired osteogenesis.
  • Signaling pathways regulating osteoblast differentiation are not fully understood.
  • Thrap3 is implicated in stem cell differentiation and biological processes.

Purpose of the Study:

  • To investigate the role of Thrap3 in osteoblast differentiation.
  • To elucidate the molecular mechanisms by which Thrap3 influences osteogenesis.
  • To identify potential therapeutic targets for osteoporosis.

Main Methods:

  • Investigated the effect of Thrap3 on osteogenesis.
  • Analyzed the interaction between Thrap3, Sox9, and Runx2.
  • Examined the impact of Thrap3 on Runx2 degradation and Sox9 transcriptional activity.

Main Results:

  • Thrap3 promotes osteogenesis by inhibiting Runx2 degradation.
  • Thrap3 physically binds to Sox9, reducing its transcriptional activity.
  • Thrap3 decreases Sox9-mediated promotion of Runx2 decomposition.
  • Established the Thrap3-Sox9-Runx2 signaling axis in osteoblast differentiation.

Conclusions:

  • Thrap3 enhances osteoblast differentiation through the Thrap3-Sox9-Runx2 axis.
  • This pathway offers a new molecular mechanism for osteogenic differentiation.
  • Thrap3 represents a potential therapeutic target for osteoporosis.
Keywords:
Runx2Sox9Thrap3osteogenesis

More Related Videos

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model08:42

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model

Published on: July 3, 2020

4.6K
Stimulation of Notch Signaling in Mouse Osteoclast Precursors08:01

Stimulation of Notch Signaling in Mouse Osteoclast Precursors

Published on: February 28, 2017

8.0K

Related Concept Videos

Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.3K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.9K
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
3.0K
Bone Remodeling01:40

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.7K
Bone Formation by Endochondral Ossification01:24

Bone Formation by Endochondral Ossification

Bone formation, or ossification, begins around the sixth to seventh week of embryonic development. Most bones develop from a cartilaginous template through the process of endochondral ossification. Cartilage formation begins when clusters of mesenchymal cells differentiate into chondrocytes. These chondrocytes proliferate rapidly and secrete an extracellular matrix that becomes encased in a membrane called the perichondrium. The resulting cartilage model provides a template that resembles the...
6.0K
Bone Formation by Intramembranous Ossification01:29

Bone Formation by Intramembranous Ossification

Intramembranous ossification is one of the two processes involved in the development of bones within an embryo. The flat bones of the face, most of the cranial bones, and the clavicles are formed via this process. During intramembranous ossification, the bones develop directly from sheets of undifferentiated mesenchymal connective tissue.
The process begins when mesenchymal cells in the embryonic skeleton gather together and differentiate into osteogenic cells, which then develop into ...
8.1K